ALL |
META-ANALYSIS |
CITATIONS |
|
Benefit-Cost Summary Statistics Per Participant | ||||||
---|---|---|---|---|---|---|
Benefits to: | ||||||
Taxpayers | $2,217 | Benefits minus costs | $11,369 | |||
Participants | $4,104 | Benefit to cost ratio | n/a | |||
Others | $531 | Chance the program will produce | ||||
Indirect | $4,138 | benefits greater than the costs | 60% | |||
Total benefits | $10,991 | |||||
Net program cost | $378 | |||||
Benefits minus cost | $11,369 | |||||
Meta-Analysis of Program Effects | ||||||||||||
Outcomes measured | Treatment age | No. of effect sizes | Treatment N | Effect sizes (ES) and standard errors (SE) used in the benefit-cost analysis | Unadjusted effect size (random effects model) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
First time ES is estimated | Second time ES is estimated | |||||||||||
ES | SE | Age | ES | SE | Age | ES | p-value | |||||
Alcohol use disorder Clinical diagnosis of alcohol use disorder or symptoms measured on a validated scale. |
39 | 6 | 627 | -0.331 | 0.132 | 39 | 0.000 | 0.187 | 42 | -0.317 | 0.016 | |
Illicit drug use disorder Clinical diagnosis of illicit drug use disorder or symptoms measured on a validated scale. When possible, we exclude cannabis/marijuana use disorder from this outcome. |
39 | 5 | 545 | -0.360 | 0.118 | 39 | 0.000 | 0.187 | 42 | -0.374 | 0.002 |
Detailed Monetary Benefit Estimates Per Participant | ||||||
Affected outcome: | Resulting benefits:1 | Benefits accrue to: | ||||
---|---|---|---|---|---|---|
Taxpayers | Participants | Others2 | Indirect3 | Total |
||
Alcohol use disorder | Criminal justice system | $1 | $0 | $2 | $0 | $2 |
Labor market earnings associated with alcohol abuse or dependence | $1,530 | $3,605 | $0 | $0 | $5,135 | |
Property loss associated with alcohol abuse or dependence | $0 | $4 | $7 | $0 | $10 | |
Illicit drug use disorder | Health care associated with illicit drug abuse or dependence | $509 | $79 | $523 | $254 | $1,364 |
Mortality associated with illicit drugs | $177 | $417 | $0 | $3,695 | $4,289 | |
Program cost | Adjustment for deadweight cost of program | $0 | $0 | $0 | $189 | $189 |
Totals | $2,217 | $4,104 | $531 | $4,138 | $10,991 | |
Detailed Annual Cost Estimates Per Participant | ||||
Annual cost | Year dollars | Summary | ||
---|---|---|---|---|
Program costs | $407 | 1993 | Present value of net program costs (in 2022 dollars) | $378 |
Comparison costs | $924 | 2014 | Cost range (+ or -) | 10% |
Benefits Minus Costs |
Benefits by Perspective |
Taxpayer Benefits by Source of Value |
Benefits Minus Costs Over Time (Cumulative Discounted Dollars) |
The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment. |
Carroll, K., Nich, C., Ball, S., Mccance, E., & Rounsavile, B. (1998). Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction, 93(5), 713-727.
Carroll, K.M., Nich, C., Shi, J.M., Eagan, D., Ball, S.A. (2012) Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: A randomized placebo-controlled trial. Drug and Alcohol Dependence, 126, 224-231.
Donovan, D.M., Daley, D.C., Brigham, G.S., Hodgkins, C.C., Perl, H. I., Garrett, S.B., Doyle, S.R., . . . Zammarelli, L. (2013). Stimulant abuser groups to engage in 12-Step: A multisite trial in the National Institute on Drug Abuse Clinical Trials Network. Journal of Substance Abuse Treatment, 44(1), 103-114
Kahler, C.W., Read, J.P., Ramsey, S.E., Stuart, G. L., McCrady, B.S., & Brown, R.A. (2004). Motivational enhancement for 12-step involvement among patients undergoing alcohol detoxification. Journal of Consulting and Clinical Psychology, 72(4), 736-741.
Kaskutas, L.A., Subbaraman, M., Witbrodt, J., Zemore, S.E. (2009) Effectiveness of Making Alcoholics Anonymous Easier (MAAEZ), a group format 12-step facilitation program. Journal of Substance Abuse Treatment, 37(3), 228-239.
Timko, C., DeBenedetti, A., & Billow, R. (2006). Intensive referral to 12-Step self-help groups and 6-month substance use disorder outcomes. Addiction, 101(5), 678-688.
Walitzer, K.S., Dermen, K.H., & Barrick, C. (2009). Facilitating involvement in Alcoholics Anonymous during out-patient treatment: a randomized clinical trial. Addiction, 104(3), 391-401.